
Share
In a world where digital health tools are increasingly crucial, Fullspan Health’s conversational AI agent is making waves with its user-friendly approach and medically vetted content.
In the realm of digital health, patient engagement and access to reliable information are paramount. Fullspan Health's conversational artificial intelligence (AI) agent, Healthline AI, has quickly become a go-to resource for many. As of August 18, the tool has attracted over 1.1 million views and engages with 13,500 individuals daily, according to Debra Harris, Head of Marketing at Fullspan Health.
“We're seeing that users average 1.6 queries per session, which translates to three conversation turns across the full exchange,” Harris said. “The depth of interaction has increased by 28% since launch, indicating a growing reliance on this tool for health-related inquiries.”
Healthline AI is designed to provide medically reviewed information, drawing exclusively from trusted sources such as Healthline, Healthgrades, Medical News Today, and Psych Central. This unique feature sets it apart from other AI tools in the market, ensuring that users receive accurate and reliable guidance.
Harris noted that three-quarters of individuals who open the tool submit a query, with 7% of sessions resulting in next-step actions. “Of those actions, 94% involve care path or provider recommendations, finding a provider, seeking a specialty, and engaging with care,” she said.
The positive user feedback is evident, with 78% of in-product reviews being favorable. Healthline AI has also managed over 2,800 diagnostic and sensitive interactions without any reported clinical or compliance issues. This robust performance underscores the tool’s reliability and effectiveness in supporting patient journeys.

“What's most important is that our AI is not just an overlay of information,” Harris emphasized. “It’s designed to provide answers and guide users to take the next step, whether it’s exploring options or getting the care they need.”
The rise of AI chatbots in healthcare reflects a broader trend towards digital solutions for improving patient access and engagement. However, concerns about control and transparency remain significant. According to a recent study, 53% of American adults feel they have little to no say in how AI is used in their care.
Fullspan Health’s approach addresses these concerns by offering transparent, medically vetted information and clear pathways for further action. As digital health tools continue to evolve, the balance between innovation and user trust will be crucial. Healthline AI’s success suggests that when done right, AI can significantly enhance patient experiences and outcomes.
In a landscape where technology is increasingly integrated into healthcare, Fullspan Health’s conversational AI agent stands out as a promising tool that not only provides information but also supports users in making informed decisions about their health. As the digital health sector continues to grow, such tools will play an essential role in bridging the gap between patients and the care they need.
Tags
Original Sources
Fullspan Health’s AI agent sees strong early traction with 1.1M views since June launch
↗ https://www.fiercehealthcare.com/ai-and-machine-learning/fullspan-healths-conversational-ai-agent-has-racked-11-million-views-june
About the author
Amara's entry point into AI was an epidemiology role at a London research hospital, where she spent five years studying how digital health tools reached — or conspicuously failed to reach — underserved communities. Watching early algorithmic systems in healthcare quietly entrench existing inequalities, she redirected her career toward the systemic consequences of AI at scale. She covers AI through an unflinching lens: who benefits, who bears the cost, and what evidence actually says versus what the press release claims. Her writing is calm and precise, but she doesn't mistake balance for neutrality.
More from The Steward →This Week's Edition
31 August 2026
85 articles
Related Articles

AIDO Cell: The Virtual Model Revolutionizing Our Understanding of Human Cells
Health & Science · 3 min

Eyepoint's Vision Treatment Falters in Key Trial, While Amylyx Sees Success
Health & Science · 4 min

Biotech Firm Akeso Faces Setback as IVONESCIMAB Trial Shows Worsening Tumor Progression
Health & Science · 3 min
Related Articles

AIDO Cell: The Virtual Model Revolutionizing Our Understanding of Human Cells
Health & Science · 3 min

Eyepoint's Vision Treatment Falters in Key Trial, While Amylyx Sees Success
Health & Science · 4 min

Biotech Firm Akeso Faces Setback as IVONESCIMAB Trial Shows Worsening Tumor Progression
Health & Science · 3 min
More Stories
© 2026 Cedar & Bloom. All rights reserved.